Implication of calpain in neuronal apoptosis - A possible regulation of Alzheimer's disease

被引:113
|
作者
Raynaud, F. [1 ]
Marcilhac, A. [1 ]
机构
[1] Univ Montpellier 2, CNRS, UMR 5539, EPHE, F-34095 Montpellier 5, France
关键词
Alzheimer's disease; apoptosis; calpain; neurodegenerative disease; neuron;
D O I
10.1111/j.1742-4658.2006.05352.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptotic neuronal cell death is the cardinal feature of aging and neurodegenerative diseases, but its mechanisms remain obscure. Caspases, members of the cysteine protease family, are known to be critical effectors in central nervous system cellular apoptosis. More recently, the calcium-dependent proteases, calpains, have been implicated in cellular apoptotic processes. Indeed, several members of the Bcl-2 family of cell death regulators, nuclear transcription factors (p53) and caspases themselves are processed by calpains. Progressive regional loss of neurons underlies the irreversible pathogenesis of various neurodegenerative diseases such as Alzheimer's disease in adult brain. Alzheimer's disease is characterized by extracellular plaques of amyloid-beta peptide aggregates and intracellular neurofibrillary tangles composed of hyperphosphorylated tau leading to apoptotic cell death. In this review, we summarize the arguments showing that calpains modulate processes that govern the function and metabolism of these two key proteins in the pathogenesis of Alzheimer's disease. To conclude, this article reviews our understanding of calpain-dependent apoptotic neuronal cell death and the ability of these proteases to regulate intracellular signaling pathways leading to chronic neurodegenerative disorders such as Alzheimer's disease. Further research on these calpain-dependent mechanisms which promote or prevent cell apoptosis should help us to develop new approaches for preventing and treating neurodegenerative disorders.
引用
下载
收藏
页码:3437 / 3443
页数:7
相关论文
共 50 条
  • [31] Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer’s Disease
    Shuhua Chen
    Tian Wang
    Jia Yao
    Roberta Diaz Brinton
    Neurotherapeutics, 2020, 17 : 1813 - 1824
  • [32] Allopregnanolone Promotes Neuronal and Oligodendrocyte DifferentiationIn VitroandIn Vivo: Therapeutic Implication for Alzheimer's Disease
    Chen, Shuhua
    Wang, Tian
    Yao, Jia
    Brinton, Roberta Diaz
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1813 - 1824
  • [33] Calpain-dependent PKC down regulation is connected with postischaemic neuronal apoptosis.
    Ziemka-Nalecz, M
    Zalewska, T
    Domanska-Janik, K
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 119 - 119
  • [34] Signalig pathways regulation neuron-glia interaction and their implication in Alzheimer's disease
    Lian, Hong
    Zheng, Hui
    JOURNAL OF NEUROCHEMISTRY, 2016, 136 (03) : 475 - 491
  • [35] Mitochondrial dysfunction and neuronal apoptosis: new molecular approach to preventing Alzheimer's disease
    Takuma, Kazuhiro
    Kataoka, Shunsuke
    Ago, Yukio
    Matsuda, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 25P - 25P
  • [36] Neuronal Networks in Alzheimer's Disease
    He, Yong
    Chen, Zhang
    Gong, Gaolang
    Evans, Alan
    NEUROSCIENTIST, 2009, 15 (04): : 333 - 350
  • [37] Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis
    Satoi, H
    Tomimoto, H
    Ohtani, R
    Kitano, T
    Kondo, T
    Watanabe, M
    Oka, N
    Akiguchi, I
    Furuya, S
    Hirabayashi, Y
    Okazaki, T
    NEUROSCIENCE, 2005, 130 (03) : 657 - 666
  • [38] Neuronal death in Alzheimer's disease
    Yanagisawa, K
    INTERNAL MEDICINE, 2000, 39 (04) : 328 - 330
  • [39] Neuronal loss in Alzheimer's disease
    Hyman, BT
    AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 10 (02): : 156 - 156
  • [40] Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease
    Ma, Qing-Hua
    Jiang, Liu-Fang
    Mao, Jian-Liang
    Xu, Wen-Xin
    Huang, Min
    MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 4113 - 4119